⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for homologous recombination (hr)

Every month we try and update this database with for homologous recombination (hr) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Efficacy and Safety Study of Niraparib in Melanoma With Genetic Homologous Recombination (HR) MutationNCT03925350
Metastatic Mela...
Niraparib
18 Years - California Pacific Medical Center Research Institute
Efficacy and Safety Study of Niraparib in Melanoma With Genetic Homologous Recombination (HR) MutationNCT03925350
Metastatic Mela...
Niraparib
18 Years - California Pacific Medical Center Research Institute
Fluzoparib in Combination With Camrelizumab and Temozolomide in Advanced MelanomaNCT05983237
Melanoma
Fluzoparib Camr...
18 Years - Peking University Cancer Hospital & Institute
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: